BioVision

BioVision

BioVision | Assay Kits, Antibodies, Recombinant Proteins, Biochemicals for Life Science Research.

Launch date
Employees
Market cap
-
Enterprise valuation
CAD464m (Public information from Aug 2021)
Milpitas California (HQ)
  • Edit
DateInvestorsAmountRound

$340m

Valuation: $340m

Acquisition
Total Funding-

Recent News about BioVision

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.